Research Article
Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study
Table 5
Reasons for discontinuing medication given in % of treatment episodes.
| ā | No effect (%) | Side effects (%) | No reason given (%) | N |
| Amitriptyline | 42.3 | 57.7 | 8.8 | 57 | NSAIDs | 83.7 | 16.3 | 7.5 | 53 | SNRI | 42.4 | 57.6 | 0 | 33 | Pregabalin | 48.3 | 51.7 | 0 | 29 | Weak opioids | 74.1 | 25.9 | 0 | 27 | Metamizole | 57.1 | 28.6 | 14.3 | 14 | Flupirtine | 84.6 | 7.7 | 7.7 | 13 | Acetaminophen | 100.0 | 0.0 | 0 | 12 | SSRI | 81.8 | 18.2 | 0 | 11 | Strong opioids | 60.0 | 40.0 | 0 | 5 | COX-2 inhibitors | 100.0 | 0.0 | 0 | 2 | Cyclobenzaprine | 33.3 | 33.3 | 33.3 | 3 | Corticosteroids | 100.0 | 0.0 | 0 | 1 | Lidocaine | 100.0 | 0.0 | 0 | 1 | All | 60.1 | 34.1 | 5.8 | 261 |
|
|
N, the total number of treatments with the respective drug in the past.
|